Published in Circulation on April 06, 2016
Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma. Cell Death Dis (2016) 0.77
A lncRNA Perspective into (Re)Building the Heart. Front Cell Dev Biol (2016) 0.77
Vascular smooth muscle cell contractile protein expression is increased through protein kinase G-dependent and -independent pathways by glucose-6-phosphate dehydrogenase inhibition and deficiency. Am J Physiol Heart Circ Physiol (2016) 0.75
Inflammation and vascular smooth muscle cell dedifferentiation following carotid artery ligation. Physiol Genomics (2016) 0.75
Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cells. Oncotarget (2017) 0.75
Epigenetics and Vascular Diseases: Influence of Non-coding RNAs and Their Clinical Implications. Front Cardiovasc Med (2017) 0.75
Transcriptome Profiling in Systems Vascular Medicine. Front Pharmacol (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods (2008) 126.81
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol (2010) 75.21
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol (2013) 32.42
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell (2007) 30.22
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A (2006) 21.58
Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol (2012) 14.01
Molecular mechanisms of long noncoding RNAs. Mol Cell (2011) 11.44
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature (2006) 10.95
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature (2010) 10.09
Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest (2005) 4.74
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation (2002) 4.43
Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science (1991) 4.27
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet (2013) 4.03
RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol (2013) 3.47
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ (2009) 3.43
FLEXBAR-Flexible Barcode and Adapter Processing for Next-Generation Sequencing Platforms. Biology (Basel) (2012) 3.07
Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation (2014) 3.04
MicroRNAs in disease and potential therapeutic applications. Mol Ther (2007) 2.73
Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res (2012) 2.28
Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol (2011) 1.98
Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler Thromb Vasc Biol (2014) 1.87
TGFβ Triggers miR-143/145 Transfer From Smooth Muscle Cells to Endothelial Cells, Thereby Modulating Vessel Stabilization. Circ Res (2015) 1.62
miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis (2011) 1.54
Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation. J Biol Chem (2014) 1.54
Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv (2011) 1.52
Tuning in to the signals: noncoding sequence conservation in vertebrate genomes. Trends Genet (2008) 1.49
Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation (2000) 1.37
Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation (1996) 1.32
Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun (2015) 1.27
Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis. Circ Res (2005) 1.23
Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Expert Rev Cardiovasc Ther (2007) 1.19
The long non-coding RNA Paupar regulates the expression of both local and distal genes. EMBO J (2014) 1.19
Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem J (1992) 1.17
Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscler Thromb Vasc Biol (2011) 1.15
MicroRNA-204 regulates vascular smooth muscle cell calcification in vitro and in vivo. Cardiovasc Res (2012) 1.14
Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis (2014) 1.11
Immune responses to dsRNA: implications for gene silencing technologies. Immunol Cell Biol (2005) 1.08
Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1alpha. J Vasc Surg (2005) 1.05
Dynamic expression of long non-coding RNAs (lncRNAs) in adult zebrafish. PLoS One (2013) 1.02
Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells. Proc Natl Acad Sci U S A (1995) 1.01
Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification. Arterioscler Thromb Vasc Biol (2012) 1.01
Lower cardiorespiratory fitness contributes to increased insulin resistance and fasting glycaemia in middle-aged South Asian compared with European men living in the UK. Diabetologia (2013) 0.99
Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Sci Rep (2014) 0.95
Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circ Res (2005) 0.95
MicroRNAs as biomarkers for myocardial infarction. Curr Atheroscler Rep (2012) 0.94
MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension. Circ Res (2015) 0.91
Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device. Eur J Heart Fail (2014) 0.90
The differential distribution of hyaluronic acid in the layers of human atheromatic aortas is associated with vascular smooth muscle cell proliferation and migration. Atherosclerosis (1998) 0.89
Crucial role of hyaluronan in neointimal formation after vascular injury. PLoS One (2013) 0.87
Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model. Drug Dev Res (2014) 0.81
Comparative effects of angiotensin receptor blockade and ACE inhibition on the fibrinolytic and inflammatory responses to cardiopulmonary bypass. Clin Pharmacol Ther (2012) 0.80
Drug-eluting stents: issues of late stent thrombosis. Cardiol Clin (2010) 0.78
Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis. PLoS One (2014) 0.78
Isolation of secreted microRNAs (miRNAs) from cell-conditioned media. Microrna (2013) 0.77
Long-term in vivo imaging of translated RNAs for gene therapy. Gene Ther (2014) 0.76